Main competitors
Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
54.88B
AAA
54.63B
A
25.06B -
A
- -
23.14B - - - -
19.87B
AAA
16.5B
AA
15.75B -
AA
- -
14.2B
BB
12.37B -
B
- -
11.84B - - - -
11.52B -
AA
- -
11.43B
B
10.76B -
BB
- -
9.83B -
CCC
- -
9.22B -
8.81B -
BBB
- -
8.61B -
CCC
- -
8.59B -
BB
- - -
8.41B -
BBB
- -
Average 17.65B
A
Weighted average by Cap.
A
Bio Therapeutic Drugs